ChiCTR-IIR-17013838
结束
泰斯花粉阻隔剂
/
泰斯花粉阻隔剂
2017-12-12
/
/
鼻炎
泰斯花粉阻隔剂对季节性和常年性变应性鼻炎患者的有效性和安全性的多中心、随机、前瞻性、双盲交叉临床研究
泰斯花粉阻隔剂对季节性和常年性变应性鼻炎患者的有效性和安全性的多中心、随机、前瞻性、双盲交叉临床研究
评估泰斯花粉阻隔剂对季节性和常年性变应性鼻炎患者的有效性和安全性
随机平行对照
Ⅱ期
随机数表
/
企业
/
55;60
/
2011-09-01
2011-12-01
/
Patients aged 6 to 60 years and diagnosed with at least 1 year of perennial AR (confirmed by clinical history, positive skin-prick tests, and serum-specific immunoglobulin E of 0.7 kU/L), with an average total nasal symptom score (TNSS) of at least 20 during the week were included in the study；
请登录查看Exclusion criteria included known hypersensitivity to ingredients in the product under investigation, severe septum deviation, nasal polyps, participation in other clinical trials within the preceding 30 days, concomitant disease that could affect the variables assessed in this study to such an extent that an objective judgment would not be possible, and women of childbearing age who are not using sufficient contraception.；
请登录查看南京医科大学第一附属医院
/
英百瑞生物2025-12-05
艾力斯医药科技2025-12-05
神曦生物NeuExcell2025-12-05
科望医药2025-12-05
宠药生态圈2025-12-05
丁香园 Insight 数据库2025-12-05
佰傲谷BioValley2025-12-05
药精通Bio2025-12-05
医药观澜2025-12-05
贝达药业2025-12-05
400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科 中国医疗人才网 医药招商网
